Mr. Speaker, throughout the COVID-19 pandemic, we continue to support community-based projects that aim to address the needs of those who use substances. We have made it easier to access medications like Suboxone and methadone, while also rapidly establishing overdose prevention sites. Our government has also dedicated $66 million to the substance use and addictions program through the fall economic statement.
The Government of Canada has not joined legal action against Purdue Pharma, McKinsey, or any other pharmaceutical companies or consultants who acted for pharmaceutical companies, in relation to how their activities may have contributed to the opioid crisis, as of January 21, 2021.